Q301--Benchmark Ultra Plus
Veterans Affairs · 257-NETWORK CONTRACT OFFICE 17 (36C257)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36C25726Q0447 in this department, oldest first.
- Apr 14, 2026 · this noticeSpecial Notice
- May 15, 2026Award NoticeROCHE DIAGNOSTICS CORPORATION · $132KOpen
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Answer the notice: this is when the requirement can still be shaped.
- Contact the contracting officer named on the notice.
- Check who won similar work; they are the likely bidders.
What the notice says
Notice of Intent to Sole Source The Department of Veterans Affairs (VA), Veterans Health Administration (VHA), Network Contracting Office (NCO) 17, intends to award a firm-fixed-price contract on a sole source basis to: � ROCHE DIAGNOSTICS CORPORATION � UEI: JDMDFEZBYH36 � 9115 Hague Road � Indianapolis, IN 46256 � Proposed Action The Government intends to award a firm-fixed-price contract on a sole source basis to Ventana Medical Systems, Inc., doing business as Roche Tissue Diagnostics, a member of the Roche Group, for one VENTANA BenchMark ULTRA PLUS Immunohistochemistry / In Situ Hybridiza… (show all)
tion (IHC/ISH) stainer system, including all required system software, uninterruptible power supply (UPS), monitor, scanner, printer, technical support, and customer training, as described in the attached Statement of Work. The contractor shall also provide installation, instrument validation guidance, preventive maintenance, on-site/off-site operator training, and technical support in accordance with manufacturer specifications. Statutory Authority This acquisition is being conducted under the authority of 41 U.S.C. 3304(a)(1), as implemented by FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements. Rationale / Justification The VA North Texas Histology section requires an additional IHC stainer to meet current and projected testing volumes and to maintain timely diagnostic services for Veteran patients. The required system must: Be a fully automated, random-access IHC/ISH staining platform capable of individual slide processing without interrupting workflow. Provide continuous loading of reagents, controls, calibrators, and samples without interruption. Include error-proof reagent and commodity design with built-in safeguards to help prevent reagent mix-ups, probe crashes, and unnecessary downtime. Offer modularity to add staining capacity as laboratory needs increase. Allow flexibility to optimize protocols, reagents, and timing to support best practices and varying tissue fixation conditions. Provide an IHC stain menu that includes, at a minimum, tissue staining options for a broad range of disease-related markers using the VENTANA assay portfolio. Be compatible with VENTANA specialized staining products currently used by the Government under existing Roche agreement. Fit within the existing laboratory footprint, with dimensions appropriate for installation in Histology Room 1B-328 at VANTHCS. Ventana Medical Systems, Inc. (Roche Tissue Diagnostics), as part of the Roche Diagnostics Division, designs and manufactures the VENTANA BenchMark ULTRA PLUS tissue staining platform and associated reagents. The BenchMark ULTRA PLUS system is an advanced evolution of the BenchMark series, providing fully automated IHC/ISH slide staining with optimized workflow, integrated touchscreen, and enhanced software and productivity features. It is specifically designed to work with the VENTANA family of tissue-based diagnostic assays, which are already in clinical use at VA and are supported under the existing Roche contract, thereby ensuring reagent compatibility and consistent, validated test performance. Substituting a different IHC platform would require extensive revalidation and correlation studies, adjustments to test protocols, and potential changes in reportable results, resulting in increased cost, extended implementation timelines, and risk of disruption to patient care. Ventana Medical Systems, Inc. (Roche Tissue Diagnostics) is therefore the only responsible source that can provide the VENTANA BenchMark ULTRA PLUS system with full compatibility to the existing VENTANA reagent menu, established workflows, and current Roche contractual framework while meeting all technical and space requirements defined in the SOW. For these reasons, only this source is considered capable of providing the required BenchMark ULTRA PLUS IHC/ISH stainer system in a manner that satisfies the Government s minimum needs without incurring unacceptable schedule, cost, and operational risk. Period and Place of Performance The contractor shall deliver, install, and validate the system at: Histology Section, Room 1B-328 Pathology & Laboratory Medicine Service VA North Texas Health Care System 4500 S. Lancaster Rd. Dallas, TX 75216 The performance period will begin upon award and continue through completion of installation, validation, training, and the applicable equipment warranty and service obligations, in accordance with the Statement of Work. Other Considerations The contractor shall provide: Delivery, installation, and setup of the instrument and all associated components. Test validation guidance and validation supplies. Basic and advanced operator training, including initial on-site training and an additional annual on-site or off-site operator class. Preventive maintenance at manufacturer-recommended intervals, including all required parts and materials, at no additional cost to the Government. Technical support during business hours and escalation to on-site support within 48 hours when required. Detailed service and maintenance reports after all preventive maintenance and repair visits. The contractor will have only supervised access while on VA premises for installation, service, and maintenance. There will be no access to the VA laboratory information system (LIS), and no VA data of any type shall be transferred from the VA. THIS NOTICE IS NOT A REQUEST FOR COMPETITIVE QUOTES This notice of intent is not a request for quotations or proposals. However, interested parties who believe they can meet the requirements described in the Statement of Work and this notice may submit a capability statement detailing their ability to provide an IHC/ISH stainer system that fully meets all required technical specifications, stain menu, footprint, and compatibility requirements. The capability statement must be received by the date and time specified in the posting and shall be sufficient to establish that the interested party can fulfill the Government s requirement without degradation of service or disruption of operations. Capability statements must be received no later than 04/ 27/ 2026, at 2:00 PM Central Standard Time (CST). Responses shall be submitted via email to: � Ognian D. Ivanov Contract Specialist, NCO 17 � Email: ognian.ivanov@va.gov A determination by the Government not to compete this requirement based on responses to this notice is solely within the discretion of the Government.
Who won similar work
20 award notices on SAM.gov in the last 24 months. Matched by: Same office (257-NETWORK CONTRACT OFFICE 17 (36C257)), same product/service code (PSC) Q301.
Single-winner award sizes (20): middle half $447K to $4.8M, median $2.0M; range $51K to $17.0M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| QUEST DIAGNOSTICS INCORPORATED · $DGX · $11.6B | 8 | $49.6M | Mar 3, 2026 |
| LABORATORY CORPORATION | 4 | $22.7M | Apr 27, 2026 |
| PROPATH SERVICES, LLC | 1 | $4.0M | Jun 11, 2026 |
| BEXAR COUNTY HOSPITAL DISTRICT SAN ANTONIO 78229 | 1 | $2.6M | Nov 20, 2024 |
| ARUP LABORATORIES INC | 1 | $450K | Mar 19, 2025 |
| VETERANS HEALTHCARE SUPPLY SOLUTIONS, INC | 1 | $438K | May 13, 2026 |
| ABBOTT LABORATORIES INC. · $ABT · $45.1B | 1 | $330K | Dec 19, 2024 |
| UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO SAN ANTONIO 78229 | 1 | $275K | Sep 22, 2025 |
| AMBRY GENETICS CORPORATION | 1 | $62K | Feb 26, 2026 |
| ABBOTT RAPID DIAGNOSTICS INFORMATICS, INC | 1 | $51K | Dec 2, 2025 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- $DGX reported $11.6B revenue (12 months to Jun 30, 2026). The median single-winner award in these 20 past awards, $2.0M, is under 0.1% of that. SEC filing
- $ABT reported $45.1B revenue (12 months to Mar 31, 2026). The median single-winner award in these 20 past awards, $2.0M, is under 0.1% of that. SEC filing
One award's total value against one year of revenue; many awards are paid over several years.
- Jun 11, 2026PROPATH SERVICES, LLC$4.0MQ301--NEW - NTX Combined Reference Lab Testing (Anatomic, Surgical, Genetic) IDIQNo listed company matched (Materiality N/A)
- May 13, 2026VETERANS HEALTHCARE SUPPLY SOLUTIONS, INC$438KQ301--WatchPat One Direct Sleep w/ServiceNo listed company matched (Materiality N/A)
- Apr 27, 2026LABORATORY CORPORATION$17.0MQ301--STX Specialized Reference Lab TestingNo listed company matched (Materiality N/A)
- Mar 29, 2026LABORATORY CORPORATION$815KQ301--South Texas VA Specialized Reference Lab Testing 3 Month OrderNo listed company matched (Materiality N/A)
- Mar 3, 2026QUEST DIAGNOSTICS INCORPORATED$12.4MQ301--Specialized Reference Lab Services BPA South Texas Veterans Healthcare SystemMateriality: 0.11% of $DGX revenue (Low) SEC
- Feb 27, 2026QUEST DIAGNOSTICS INCORPORATED$12.8MQ301--Reference Laboratory Testing Services BPA El Paso Veterans Healthcare SystemMateriality: 0.11% of $DGX revenue (Low) SEC
- Feb 27, 2026QUEST DIAGNOSTICS INCORPORATED$5.5MQ301--New - NTX Reference TestingMateriality: 0.05% of $DGX revenue (Low) SEC
- Feb 26, 2026AMBRY GENETICS CORPORATION$62KQ301--Specialized Genetic Testing ServicesNo listed company matched (Materiality N/A)
- Jan 20, 2026QUEST DIAGNOSTICS INCORPORATED$4.6MQ301--Reference Laboratory Services Central Texas Veterans Healthcare SystemMateriality: 0.04% of $DGX revenue (Low) SEC
- Jan 7, 2026QUEST DIAGNOSTICS INCORPORATED$2.0MWest Texas VA Reference Lab TestingMateriality: 0.02% of $DGX revenue (Low) SEC
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 1 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (5 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- $69K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Veterans' Affairs, Senate Committee on Appropriations, Senate Committee on Veterans' Affairs
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 5 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 2 of the past winners are listed companies
- 0 insider buys and 5 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.